SCHEMBL8535547

SCHEMBL8535547

CC1NC(=O)OC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8535544 1.00
SCHEMBL13637170 0.73
SCHEMBL2365875 0.70
SCHEMBL2369418 0.70
SCHEMBL2365869 0.70
SCHEMBL3924875 0.70
SCHEMBL1488846 0.69 CHRNA7 (0.33)
SCHEMBL17589072 0.69 ALDH1A1 (0.31)
SCHEMBL15209958 0.69
SCHEMBL3290650 0.69 HTT (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5801249-A Chiral auxiliaries OXFORD ASYMMETRY INTERNATIONAL PLC (GB) 1998-09-01 US claimed
WO-1995018112-A1 IMPROVEMENTS IN OR RELATING TO CHIRAL AUXILIARIES OXFORD ASYMMETRY LIMITED (GB) 1995-07-06 WO claimed
US-10729688-B2 Hepatitis B antiviral agents ENANTA PHARMACEUTICALS, INC. (US) 2020-08-04 US disclosed
US-20190321360-A1 HEPATITIS B ANTIVIRAL AGENTS ENANTA PHARMACEUTICALS, INC. 2019-10-24 US disclosed
WO-2019191166-A1 HEPATITIS B ANTIVIRAL AGENTS ENANTA PHARMACEUTICALS, INC. (US) 2019-10-03 WO disclosed
US-5801249-A Chiral auxiliaries OXFORD ASYMMETRY INTERNATIONAL PLC (GB) 1998-09-01 US disclosed
WO-1995018112-A1 IMPROVEMENTS IN OR RELATING TO CHIRAL AUXILIARIES OXFORD ASYMMETRY LIMITED (GB) 1995-07-06 WO disclosed